GBI Secures Commercial Manufacturing Contract, Solidifying Leadership in Radiopharmaceutical Manufacturing
Experience.
History-Making.
BIO International Convention
June 3-6, 2024 San Diego Convention Center111 West Harbor Drive, San Diego
CA, 92101
Antibody-Oligonucleotide Conjugates Clinical Manufacturing – A new paradigm shift of Bio-Conjugates for Therapeutics
GBI Role in Bioconjugation for Radiopharmaceuticals and Other Emerging Therapies
Expediting Radioimmune Conjugate Pharmaceuticals for First-In-Human Phase 0 Proof-of-Concept Human Studies from Stable Pool
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Overcoming Scalability in Biologics: CDMO Strategies for Success
Sandra Isaacs, Director, Quality Assurance Department – Women in STEM
Maria F. Lechuga, Biochemist, Sr. Manager of Quality Control Analytical Department – Women in STEM
Future Trends in Sterile Fill Finish Technology: What’s on the Horizon?
